---

📊 Wyckoff Market Intelligence Scorecard

• Market Phase: Transition (Late Distribution → Early Re-Accumulation Attempt)
• Market Health Index: 52 → Improving (Early Stage)
• Trend Structure: Range Expansion Attempt (Resistance Test Underway)
• Volume Signature: Demand Returning (Selective, Not Broad)
• Momentum (Technometer): ~50 → Neutral / No Edge
• Capital Rotation: Strong Rotation → Commodities, Biotech, Dollar
• Risk Environment: Selective Risk-On (Not Confirmed Trend)

👉 Summary:
This is no longer pure weakness — but it is NOT a confirmed bull trend.
We are in a rotation-driven transition environment.

---

🌍 Macro Market Backdrop

The macro picture continues to create conflicting signals, which is exactly why this environment is difficult for most traders.

• Inflation pressure still lingering (supports commodities intermittently)
• Rates volatility → continues to cap aggressive equity upside
• Dollar strength emerging again (important shift)

👉 The key macro shift this week:
Capital is no longer flowing uniformly into equities — it is rotating.

That is classic late-cycle / transition behavior.

---

🧭 Market Barometer

SPY

• Testing range resistance (~695 area) after sharp rally off lows
• Prior weakness showed Phase D behavior (SOW / FTI / MKDN)
• Current rally = reaction rally into supply

👉 Key Read:

• This is a test of supply — not confirmed strength yet
• Needs acceptance above resistance to shift bias

---

QQQ

• Similar structure: rally back into upper range supply (~630 area)
• Previous breakdown structure still intact beneath

👉 Key Read:

• Tech is participating, but not leading
• Rally lacks decisive leadership characteristics

---

📈 Campaign Structure — Leadership Stocks

XLE (Energy)

• Still structurally strong longer-term
• Recent pullback = normal within uptrend channel
• No confirmed breakdown

👉 Remains institutional-quality trend, but losing momentum short-term

---

XBI (Biotech)

• Clean Wyckoff accumulation → SOS → breakout
• Strong relative strength improvement

👉 Trade completed (+5.5%) — correct execution

• Strength confirmed → profit taken into expansion

---

UUP (US Dollar)

• Emerging accumulation → early markup attempt
• Improving OP + structure

👉 This is new leadership attempt

• Important because strong dollar = pressure on equities

---

📈 Existing Positions

• TDS → Holding (structure intact)
• XLE / NBR / ENB / LNT → Trend positions (energy/utilities exposure)
• MRK / FIHL → Defensive / selective strength

Updates:

• ✅ XBI SOLD (+5.5%) → Correct tactical execution
• ❌ CDRE SOLD (loss) → Lack of follow-through = correct exit
• 🆕 UUP ADDED → Dollar strength rotation play

👉 Portfolio now reflects:

• Defensive + commodity + currency exposure
• Reduced equity beta → intentional positioning

---

🔄 Sector Rotation + Leadership Dashboard

🟢 Leadership

• GDX (Score 71) → Clear leadership (hard assets confirming)

🟡 Strong Improving Groups

• XBI (64), KRE (58), XLB (57), IBB (57)
• Rotation into:
  • Biotech
  • Materials
  • Financials (selectively)

🟠 Mixed / Weak Areas

• XLE (46) → losing relative strength short-term
• Defensives (XLV, XLP) → not leading
• Tech mixed (XLK / SMH improving but not dominant)

👉 Key Insight:
This is NOT a broad bull market

This is:
➡️ Fragmented rotation
➡️ Selective leadership pockets
➡️ Institutional repositioning

---

⚖️ Weight Of Evidence (Update)

Bullish Factors:

• Demand returning in SPY/QQQ
• Rotation improving across multiple sectors
• Biotech + Materials showing strength

Bearish Factors:

• Price still at resistance (not confirmed breakout)
• Dollar strengthening (macro headwind)
• Leadership not broad-based
• Prior distribution structure still relevant

👉 Net Read:
Neutral → Slightly Bullish (but fragile)

---

📌 Market Conclusion

The market is transitioning — but not resolved.

What most traders are calling:
👉 “New uptrend”

Is actually:
👉 A test of supply within a larger range

Meanwhile:

• Rotation is accelerating
• Leadership is shifting
• Macro pressure is still present

👉 This is a decision zone — not a breakout environment

---

🎯 ProTraders Focus

This is where we gain edge:

• Avoid chasing broad index strength
• Focus on rotation leaders ONLY
• Continue managing risk tightly in range conditions

Key Focus Areas:

• Biotech (already delivered)
• Materials / Hard Assets
• Dollar strength implications
• Select financials

---

🧠 Tactical Outlook

Two paths from here:

Scenario 1 (Bullish)

• SPY / QQQ break and HOLD above resistance
• Rotation broadens
  👉 Then we increase exposure

Scenario 2 (More Likely Right Now)

Rotation continues underneath
👉 Best trades remain selective, not index-driven

Rally fails at resistance

---

---

Disclaimer

This report is for educational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All analysis is based on the Wyckoff Method of market interpretation.

© WyckoffSMI — All Rights Reserved

---